Browse > Article
http://dx.doi.org/10.5851/kosfa.2017.37.1.1

Chicken Egg Yolk Antibodies (IgY) for Prophylaxis and Treatment of Rotavirus Diarrhea in Human and Animal Neonates: A Concise Review  

Thu, Hlaing Myat (Department of Medical Research)
Myat, Theingi Win (Department of Medical Research)
Win, Mo Mo (Department of Medical Research)
Thant, Kyaw Zin (Department of Medical Research)
Rahman, Shofiqur (Immunology Research Institute in Gifu, EW Nutrition Japan)
Umeda, Kouji (Immunology Research Institute in Gifu, EW Nutrition Japan)
Nguyen, Sa Van (Immunology Research Institute in Gifu, EW Nutrition Japan)
Icatlo, Faustino C. Jr. (Immunology Research Institute in Gifu, EW Nutrition Japan)
Higo-Moriguchi, Kyoko (Department of Virology and Parasitology, Fujita Health University School of Medicin)
Taniguchi, Koki (Department of Virology and Parasitology, Fujita Health University School of Medicin)
Tsuji, Takao (Department of Microbiology, Fujita Health University School of Medicine)
Oguma, Keiji (Department of Bacteriology, Okayama University Graduate School of Medicine)
Kim, Sang Jong (Dairy Team, Lotte R&D Center)
Bae, Hyun Suk (Dairy Team, Lotte R&D Center)
Choi, Hyuk Joon (BK bio)
Publication Information
Food Science of Animal Resources / v.37, no.1, 2017 , pp. 1-9 More about this Journal
Abstract
The rotavirus-induced diarrhea of human and animal neonates is a major public health concern worldwide. Until recently, no effective therapy is available to specifically inactivate the rotavirion particles within the gut. Passive immunotherapy by oral administration of chicken egg yolk antibody (IgY) has emerged of late as a fresh alternative strategy to control infectious diseases of the alimentary tract and has been applied in the treatment of diarrhea due to rotavirus infection. The purpose of this concise review is to evaluate evidence on the properties and performance of anti-rotavirus immunoglobulin Y (IgY) for prevention and treatment of rotavirus diarrhea in human and animal neonates. A survey of relevant anti-rotavirus IgY basic studies and clinical trials among neonatal animals (since 1994-2015) and humans (since 1982-2015) have been reviewed and briefly summarized. Our analysis of a number of rotavirus investigations involving animal and human clinical trials revealed that anti-rotavirus IgY significantly reduced the severity of clinical manifestation of diarrhea among IgY-treated subjects relative to a corresponding control or placebo group. The accumulated information as a whole depicts oral IgY to be a safe and efficacious option for treatment of rotavirus diarrhea in neonates. There is however a clear need for more randomized, placebo controlled and double-blind trials with bigger sample size to further solidify and confirm claims of efficacy and safety in controlling diarrhea caused by rotavirus infection especially among human infants with health issues such as low birth weights or compromised immunity in whom it is most needed.
Keywords
Rotavirus; diarrhea disease; neonates; oral passive immunotherapy; IgY;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Rahman, S., Higo-Moriguchi, K., Htun, K. W., Taniguchi, K., Icatlo, F. C., Jr., Tsuji, T., Kodama, Y., van Nguyen, S., Umeda, K., Oo, H. N., Myint, Y. Y., Htut, T., Myint, S. S., Thura, K., Thu, H. M., Fatmawati, N. N., and Oguma, K. (2012) Randomized placebo-controlled clinical trial of immunoglobulin Y as adjunct to standard supportive therapy for rotavirus-associated diarrhea among pediatric patients. Vaccine 30, 4661-4669.   DOI
2 Rahman, S., Nguyen, S., Icatlo, F., Umeda, K., and Kodama, Y. (2013a) Oral passive IgY-based immunotherapeutics: A novel solution for prevention and treatment of alimentary tract diseases. Hum. Vaccines Immunotherapeutics 9, 1039-1048.   DOI
3 Rahman, S., Umeda, K., Icatlo, Jr. F. C., Lee, K. W., Kim, S. H., Choi, H. J., Han, B. K., Park, Y. S., and Sa, N. V. (2013b) In vitro cytoprotective effect of infant milk formula fortified with human rotavirus-specific hyperimmune yolk immunoglobulins (IgY). Food Sci. Biotechnol. 22, 1699-1705.   DOI
4 Robert, F. R. (2004) Pathogenesis of intestinal and systemicrotavirus infection. J. Virol. 78, 10213-10220.   DOI
5 Sarker, S. A., Casswall, T. H., Juneja, L. R., Hoq, E., Hossain, I., Fuchs, G. J., and Hammarström L. (2001) Randomized, placebo-controlled, clinical trial of hyperimmunized chicken egg yolk immunoglobulin in children with rotavirus diarrhea. J. Pediatr. Gastroenterol. Nutr. 32, 19-25.   DOI
6 Selvan, K., Sentila, R., and Michael, A. (2012) Generation and characterization of chicken egg yolk antibodies against Propionibacterium acnes for the prevention of acne Vulgaris. Ind. J. Dermatol. 57, 15-19.   DOI
7 Shin, J. H., Yang, M., Nam, S.W., Kim, J. T., Myung, N. H., Bang, W.G., and Roe, I. H. (2002) Use of egg yolk-derived immunoglobulin as an alternative to antibiotic treatment for control of Helicobacter pylori infection. Clin. Diagn. Lab. Immunol. 9, 1061-1066.
8 Nilsson, E., Larsson, A., Olesen, H.V., Wejåker, P. E., and Kollberg, H. (2008) Good effect of IgY against Pseudomonas aeruginosa infections in cystic fibrosis patients. Pediatr Pulmonol. 43, 892-899.   DOI
9 Müller, S., Schubert, A., Zajac, J., Dyck, T., and Oelkrug, C. (2015) IgY antibodies in human nutrition for disease prevention. Nutr. J. 14, 109.   DOI
10 Neri, P., Tokoro, S., Sugiyama, T., Umeda, K., Shimizu, T., Tsuji, T., Kodama Y., and Mori, H. (2012) Recombinant Shiga toxin B subunit can induce neutralizing immunoglobulin Y antibody. Biol. Pharm. Bull. 35, 917-923.   DOI
11 Nguyen, H. H., Tumpey, T. M., Park, H. J., Byun, Y. H., Tran, L. D., Nguyen, V. D., Kilgore, P. E., Czerkinsky, C., Katz, J. M., Seong, B. L., Song, J. M., Kim, Y. B., Do, H. T., Nguyen,T., and Nguyen, C. V. (2010) Prophylactic and therapeutic efficacy of avian antibodies against influenza virus H5N1 and H1N1 in mice. PLoS ONE. 5, e10152.   DOI
12 Raffatellu, M. and Baumler, A. J. (2010) Salmonella's iron armor for battling the host and its microbiota. Gut Microbes. 1,70-72.   DOI
13 Nguyen, S. V., Icatlo, Jr. F. C., Nakano, T., Isogai, E., Hirose, K., Mizugai, H., Kobayashi-Sakamoto, M., Isogai, H., and Chiba, I. (2011) Anti cell-associated glucosyltransferase immunoglobulin Y suppression of salivary mutans streptococciin healthy young adults. J. Ame. Dent. Assoc. 142, 943-949.   DOI
14 Pammi, M. and Haque, K. N. (2011) Oral immunoglobulin for the treatment of rotavirus diarrhea in low birth weight infants. Cochrane Database Syst. Rev. 5.
15 Parr, R. D., Storey, S. M., Mitchell, D. M., McIntosh, A. L., Zhou, M., Mir, K. D., and Ball, J. M. (2006) The rotavirus enterotoxin NSP4 directly interacts with the caveolar structuralprotein caveolin-1. J. Virol. 80, 2842-2854.   DOI
16 Kollberg, H. (2015) Avian antibodies (IgY) to fight antibiotic resistance. Clin. Microbiol. 4, 2. 1000194.
17 Hlaing, M. T., Theingi, W. M., Mo Mo, W., Kyaw, Z. T., Rahman, S., Umeda, K., Nguyen, V. S., Icatlo, F. C., Jr., Moriguchi, K. H., Taniguchi, K., Tsuji. T., and Oguma, K. (2015). Immunoglobulin Y-fortified infant milk formula as adjunct to treatment of diarrhea among rotavirus-infected hospitalized children in Myanmar: a randomized, double-blind, placebo-controlled trial. Unpublished data.
18 Ibrahim, El-S. M., Rahman, A. K. M. S., Isoda, R., Umeda, K., van Sa, N., and Kodama Y. (2008) In vitro and in vivo effectiveness of egg yolk antibody against Candida albicans (anti-CA IgY). Vaccine 26, 2073-2080.   DOI
19 Ikemori, Y, Peralta, R.C., Kuroki, M., Yokoyama, H., and Kodama Y. (1993) Avidity of chicken yolk antibodies to enterotoxigenic Escherichia coli fimbriae. Poult Sci. 72, 2361-2365.   DOI
20 Ikemori, Y., Ohta, M., Umeda, K., Peralta, R. C., Kuroki, M., Yokoyama, H., and Kodama, Y. (1996) Passage of chicken egg yolk antibody treated with hydroxypropyl methylcellulose phthalate in the gastrointestinal tract of calves. J. Vet. Med. Sci. 58, 365-367.   DOI
21 Lee, C. H., Lee, Y. C., Liang, M. H., Leu, S. J., Lin, L. T., Chiang, J. R., and Yang, Y. Y. (2015) Antibodies against venom of the snake Deinagkistrodon acutus. Appl. Environ. Microbiol. 82, 71-80.
22 Lee, K. E., Han, B. K., Han, J. Y., Hong, J. Y., Kim, M. N., Heo, W. I., Sohn, M. H., Kim, K. W., and Kim, K. E. (2014) Production of egg yolk antibodies specific to house dust mite proteins. Yonsei Med. J. 55, 999-1004.   DOI
23 Li, X. Y., Jin, L. J., Uzonna, J. E., Li, S. Y., Liu, J. J., Li, H. Q., Lu, Y. N., Zhen, Y. H., and Xu, Y. P. (2009) Chitosan-alginate microcapsules for oral delivery of egg yolk immunoglobulin (IgY): In vivo evaluation in a pig model of enteric colibacillosis. Vet. Immunol. Immunopathol. 129, 132-136.   DOI
24 Diraviyam, T., Zhao, B., Wang, Y., Schade, R., Michael A., and Zhang, X. (2014) Effect of chicken egg yolk antibodies (IgY) against diarrhea in domesticated animals: A systematic review and meta-analysis. PLoS ONE 9, e97716.   DOI
25 Bhavnani, D., Goldstick, J. E., Cevallos, W., Trueba, G., and Eisenberg, J. N. S. (2012) Synergistic effects between rotavirus and coinfecting pathogens on diarrheal disease: Evidence from a community-based study in Northwestern Ecuador. Am. J. Epidemiol. 176, 387-395.   DOI
26 Dai, Y. C., Wang, Y. Y., Zhang, X. F., Tan, M., Xia, M., Wu, X. B., Jiang, X., and Nie, J. (2012) Evaluation of anti-norovirus IgY from egg yolk of chickens immunized with norovirus P particles. J. Virol. Methods 186, 126-131.   DOI
27 Dhama, K., Chauhan, R. S., Mahendran, M., and Malik, S. V. S. (2009) Rotavirus diarrhea in bovines and other domesticated animals. Vet. Res. Comm. 33, 1-23.
28 Gujral, N., Löbenberg, R., Suresh, M., and Sunwoo, H. (2012) In vitro and in vivo binding activity of chicken egg yolk immunoglobulin Y (IgY) against gliadin in food matrix. J. Agric. Food Chem. 60, 3166-3172.   DOI
29 Hatta, H., Tsuda, K., Akachi, S., Kim, M., Yamamoto, T., and Ebina, T. (1993) Oral passive immunization effect of antihuman rotavirus IgY and its behavior against proteolytic enzymes. Biosci. Biotechnol. Biochem. 57, 1077-1081.   DOI
30 Hirai, K., Arimitsu, H., Umeda, K., Yokota, K., Shen, L., Ayada, K., Kodama, Y., Tsuji, T., Hirai, Y., and Oguma, K. (2010) Passive oral immunization by egg yolk immunoglobulin (IgY) to Vibrio cholerae effectively prevents cholera. Acta Med. Okayama. 64, 163-170.
31 Yokoyama, K., Sugano, N., Shimada, T., Shofiqur, R. A., Ibrahim, El-S. M., Isoda, R., Umeda, K., van Sa, N., Kodama,Y., and Ito, K. (2007) Effects of egg yolk antibody against Porphyromonas gingivalis gingipains in periodontitis patients. J. Oral Sci. 49, 201-206.   DOI
32 Arimitsu, H., Sasaki, K., Kohda, T., Shimizu, T., and Tsuji, T. (2014) Evaluation of Shiga toxin 2e-specific chicken egg yolk immunoglobulin: Production and neutralization activity. Microbiol. Immunol. 58, 643-648.   DOI
33 Barnes, G. L., Hewson, P. H., Mclellan, J. A., Doyle, L. W., Knoches, A. M. L., and Kitchen,W. H. (1982) A randomised trial of oral gammaglobulin in low-birth-weight infants infected with rotavirus. The Lancet. 319, 1371-1373.   DOI
34 Baumler, A. J. and Sperandio, V. (2016) Interactions between the microbiota and pathogenic bacteria in the gut. Nature 535, 85-93.   DOI
35 Hirose, M., Ando, T., Shofiqur R., Umeda K., Kodama Y., Nguyen S. V., Goto, T., Shimada, M., and Nagaoka, S. (2013) Anti-obesity activity of hen egg anti-lipase immunoglobulin yolk, a novel pancreatic lipase inhibitor. Nutr. Metab. (Lond). 10, 70.   DOI
36 Suzuki, H., Nomura, S., Masaoka, T., Goshima, H., Kamata, N., Kodama Y, Ishii, H., Kitajima, M., Nomoto, K., and Hibi, T. (2004) Effect of dietary anti-Helicobacter pylori-urease immunoglobulin Y on Helicobacter pylori infection. Aliment Pharmacol. Therapeut. 20, 185-192.   DOI
37 Vega, C., Bok, M., Saif, L., Fernandez, F., and Parreno, V. (2015) Egg yolk IgY antibodies: A therapeutic intervention against group A rotavirus in calves. Res. Vet. Sci. 103, 1-10.   DOI
38 Yokoyama, H., Peralta, R. C., Sendo, S., Ikemori, Y., and Kodama, Y. (1993) Detection of passage and absorption of chicken egg yolk immunoglobulins in the gastrointestinal tract of pigs by use of enzyme-linked immunosorbent assay and fluorescent antibody testing. Am. J. Vet. Res. 54, 867-872.